neurological thrombectomy device is an investigational device. for Stroke

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Stroke+5 Moreneurological thrombectomy device is an investigational device. - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a new device that removes clots in people with acute ischemia (lack of blood flow).

Eligible Conditions
  • Stroke

Treatment Effectiveness

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 90 days

90 days
Evaluate technical efficacy outcomes with radiographical measurements
day 1
outcomes with radiographical measurements

Trial Safety

Trial Design

1 Treatment Group

neurological thrombectomy device
1 of 1

Experimental Treatment

15 Total Participants · 1 Treatment Group

Primary Treatment: neurological thrombectomy device is an investigational device. · No Placebo Group · N/A

neurological thrombectomy device
Device
Experimental Group · 1 Intervention: neurological thrombectomy device is an investigational device. · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 90 days

Who is running the clinical trial?

University at Buffalo Jacobs InstituteUNKNOWN
University at BuffaloLead Sponsor
123 Previous Clinical Trials
93,599 Total Patients Enrolled
2 Trials studying Stroke
403 Patients Enrolled for Stroke

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: